Translationell bröstcancerforskning: långsiktig risk och endokrin behandlingsnytta – Linda Lindströms forskargrupp

Publikationer

Utvalda publikationer

• Article: JOURNAL OF CLINICAL ONCOLOGY. 2022;40(35):4071-4082

  Twenty-Year Benefit From Adjuvant Goserelin and Tamoxifen in Premenopausal Patients With Breast Cancer in a Controlled Randomized Clinical Trial

  Johansson A; Dar H; Veer LJVT; Tobin NP; Perez-Tenorio G; Nordenskjold A; Johansson U; Hartman J; Skoog L; Yau C; Benz CC; Esserman LJ; Stal O; Nordenskjold B; Fornander T; Lindstrom LS
• Article: JAMA NETWORK OPEN. 2021;4(6):e2114904

  Assessment of 25-Year Survival of Women With Estrogen Receptor-Positive/ERBB2-Negative Breast Cancer Treated With and Without Tamoxifen Therapy A Secondary Analysis of Data From the Stockholm Tamoxifen Randomized Clinical Trial

  Dar H; Johansson A; Nordenskjold A; Iftimi A; Yau C; Perez-Tenorio G; Benz C; Nordenskjold B; Stal O; Esserman LJ; Fornander T; Lindstrom LS
• Article: JAMA NETWORK OPEN. 2021;4(6):e2114716

  Characterization of Benign Breast Diseases and Association With Age, Hormonal Factors, and Family History of Breast Cancer Among Women in Sweden

  Johansson A; Christakou AE; Iftimi A; Eriksson M; Tapia J; Skoog L; Benz CC; Rodriguez-Wallberg KA; Hall P; Czene K; Lindstrom LS
• Article: JAMA ONCOLOGY. 2019;5(9):1304-1309

  Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer

  Yu NY; Iftimi A; Yau C; Tobin NP; van 't Veer L; Hoadley KA; Benz CC; Nordenskjold B; Fornander T; Stal O; Czene K; Esserman LJ; Lindstrom LS
• Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2018;110(7):726-733

  Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer

  Lindstrom LS; Yau C; Czene K; Thompson CK; Hoadley KA; van't Veer LJ; Balassanian R; Bishop JW; Carpenter PM; Chen Y-Y; Datnow B; Hasteh F; Krings G; Lin F; Zhang Y; Nordenskjold B; Stal O; Benz CC; Fornander T; Borowsky AD; Esserman LJ
• Article: JAMA ONCOLOGY. 2017;3(11):1503-1510

  Use of Molecular Tools to Identify Patients With Indolent Breast Cancers With Ultralow Risk Over 2 Decades

  Esserman LJ; Yau C; Thompson CK; van't Veer LJ; Borowsky AD; Hoadley KA; Tobin NP; Nordenskjold B; Fornander T; Stal O; Benz CC; Lindstrom LS
• Article: ANNALS OF ONCOLOGY. 2015;26(1):81-88

  Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival

  Tobin NP; Harrell JC; Lövrot J; Egyhazi Brage S; Frostvik Stolt M; Carlsson L; Einbeigi Z; Linderholm B; Loman N; Malmberg M; Walz T; Fernö M; Perou CM; Bergh J; Hatschek T; Lindström LS
• Article: ANNALS OF ONCOLOGY. 2014;25(10):1966-1972

  Prognostic information of a previously diagnosed sister is an independent prognosticator for a newly diagnosed sister with breast cancer

  Lindstrom LS; Li J; Lee M; Einbeigi Z; Hartman M; Hall P; Czene K
• Article: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(21):2601-2608

  Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression

  Lindstrom LS; Karlsson E; Wilking UM; Johansson U; Hartman J; Lidbrink EK; Hatschek T; Skoog L; Bergh J
• Article: LANCET ONCOLOGY. 2007;8(11):1001-1006

  Familial concordance in cancer survival:: a Swedish population-based study

  Lindstrom LS; Hall P; Hartman M; Wiklund F; Gronberg H; Czene K

Medarbetare och kontakt

Gruppledare

• 

  Linda Lindström

  Senior Forskare | Docent

  Telefon +46852488117

  E-postadress linda.lindstrom@ki.se

Alla medarbetare i gruppen

• Paula Camargo Romera

  Doktorand

  E-postadress paula.camargo.romera@ki.se
• Miguel Castresana-Aguirre

  Postdoktor

  E-postadress miguel.castresana.aguirre@ki.se
• Oscar Danielsson

  Assistent Klinisk

  E-postadress oscar.danielsson@ki.se
• Tommy Fornander

  Anknuten till Forskning | Docent

  E-postadress tommy.fornander@ki.se
• Elham Hedayati

  Adjungerad Lektor | Anknuten till Forskning | Docent

  E-postadress elham.hedayati@ki.se
• 

  Annelie Johansson

  Anknuten till Forskning

  E-postadress annelie.johansson@ki.se
• 

  Aina Johnsson

  Anknuten till Forskning

  E-postadress aina.johnsson@ki.se
• Annelie Liljegren

  Anknuten till Forskning | Docent

  E-postadress annelie.liljegren@ki.se
• 

  Linda Lindström

  Senior Forskare | Docent

  Telefon +46852488117

  E-postadress linda.lindstrom@ki.se
• Kankana Roy

  Anknuten till Forskning

  E-postadress kankana.roy@ki.se
• Per Rydberg

  Forskningsspecialist

  E-postadress per.rydberg@ki.se
• Magdalena Ríos Romero

  Postdoktorala Studier

  E-postadress magdalena.rios.romero@ki.se
• Jacob Thurell

  Anknuten till Forskning

  E-postadress jacob.thurell@ki.se
• 

  Nick Tobin

  Adjunkt | Senior Forskare | Docent

  E-postadress nick.tobin@ki.se
• 

  Julia Tutzauer

  Postdoktor

  E-postadress julia.tutzauer@ki.se
• Jo de Vos

  Doktorand

  E-postadress jo.de.vos@ki.se

Teams

Cancergenomik och AI - Nick Tobin

Foto: N/A

Cancergenomik och AI - Nick Tobin

Vi studerar de molekylära mekanismerna bakom cancer med hjälp av storskaliga genomiska data och avancerade beräkningsmetoder. Genom att integrera bioinformatik och artificiell intelligens strävar vi efter att förbättra diagnostik, prognos och behandlingsstrategier inom onkologi.